Treatment of subcutaneous calcinosis in systemic disorders;Traitement des calcinoses sous-cutanées des connectivites

Revue de Medecine Interne

Volumn 35, Issue 7, 2014, Pages 444-452

  Bienvenu, B ^a,b  

^a UNIVERSITÉ DE CAEN   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Calcinosis cutis; Treatment

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; COLCHICINE; MINOCYCLINE; WARFARIN;

CALCINOSIS; DERMATOMYOSITIS; HUMAN; SCLERODERMA, SYSTEMIC;

CALCINOSIS; CALCIUM CHANNEL BLOCKERS; COLCHICINE; DERMATOMYOSITIS; HUMANS; MINOCYCLINE; SCLERODERMA, SYSTEMIC; WARFARIN;

EID: 84903585382     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2014.04.018     Document Type: Short Survey

References (63)

1. Walsh J.S., Fairley J.A. Calcifying disorders of the skin. J Am Acad Dermatol 1995, 33:693-706. [quiz 7-10].
2. Gutierrez A., Wetter D.A. Calcinosis cutis in autoimmune connective tissue diseases. Dermatol Ther 2012, 25:195-206.
3. Touart D.M., Sau P. Cutaneous deposition diseases. Part I. J Am Acad Dermatol 1998, 39:72-74. [149-71; quiz].
4. Wilmer W.A., Magro C.M. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002, 15:172-186.
5. Reiter N., El-Shabrawi L., Leinweber B., Berghold A., Aberer E. Calcinosis cutis: part I. Diagnostic pathway. J Am Acad Dermatol 2011, 65:3-4. [1-12; quiz].
6. Chander S., Gordon P. Soft tissue and subcutaneous calcification in connective tissue diseases. Curr Opinion Rheumatol 2012, 24:158-164.
7. Balin S.J., Wetter D.A., Andersen L.K., Davis M.D. Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78patients, 1996-2009. Arch Dermatol 2012, 148:455-462.
8. Shimizu M., Ueno K., Ishikawa S., Kasahara Y., Yachie A. Role of activated macrophage and inflammatory cytokines in the development of calcinosis in juvenile dermatomyositis. Rheumatology (Oxford) 2014, 53:766-767.
9. Gushi A., Kanekura T., Mochitomi Y., Kawabata H., Kanzaki T. Pseudoxanthoma elasticum (PXE)-like calcification in adult dermatomyositis. J Dermatol 2002, 29:423-426.
10. Pugashetti R., Shinkai K., Ruben B.S., Grossman M.E., Maldonado J., Fox L.P. Calcium may preferentially deposit in areas of elastic tissue damage. J Am Acad Dermatol 2011, 64:296-301.
11. Vayssairat M., Hidouche D., Abdoucheli-Baudot N., Gaitz J.P. Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression?. Ann Rheum Dis 1998, 57:252-254.
12. Boulman N., Slobodin G., Rozenbaum M., Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum 2005, 34:805-812.
13. Caso F., Costa L., Atteno M., Sfriso P., Cozzi F., Cantarini L., et al. The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome. Int J Rheum Dis 2013, 16:495-496.
14. Robertson L.P., Marshall R.W., Hickling P. Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline. Ann Rheum Dis 2003, 62:267-269.
15. Bowyer S.L., Blane C.E., Sullivan D.B., Cassidy J.T. Childhood dermatomyositis: factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983, 103:882-888.
16. Rothe M.J., Grant-Kels J.M., Rothfield N.F. Extensive calcinosis cutis with systemic lupus erythematosus. Arch Dermatol 1990, 126:1060-1063.
17. Eastham A.B., Velez N.F., Chesebro A.L., Townsend H.B., Vleugels R.A. Diffuse dystrophic calcinosis cutis of the scalp in a patient with scalp discoid lupus erythematosus and systemic lupus erythematosus. JAMA Dermatol 2013, 149:246-248.
18. Gunawardena H., Wedderburn L.R., Chinoy H., Betteridge Z.E., North J., Ollier W.E., et al. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 2009, 60:1807-1814.
19. Pachman L.M., Liotta-Davis M.R., Hong D.K., Kinsella T.R., Mendez E.P., Kinder J.M., et al. TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum 2000, 43:2368-2377.
20. Palmieri G.M., Sebes J.I., Aelion J.A., Moinuddin M., Ray M.W., Wood G.C., et al. Treatment of calcinosis with diltiazem. Arthritis Rheum 1995, 38:1646-1654.
21. Oliveri M.B., Palermo R., Mautalen C., Hubscher O. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol 1996, 23:2152-2155.
22. Wang W.J., Lo W.L., Wong C.K. Calcinosis cutis in juvenile dermatomyositis: remarkable response to aluminum hydroxide therapy. Arch Dermatol 1988, 124:1721-1722.
23. Nassim J.R., Connolly C.K. Treatment of calcinosis universalis with aluminium hydroxide. Arch Dis Child 1970, 45:118-121.
24. Park Y.M., Lee S.J., Kang H., Cho S.H. Large subcutaneous calcification in systemic lupus erythematosus: treatment with oral aluminum hydroxide administration followed by surgical excision. J Korean Med Sci 1999, 14:589-592.
25. Fuchs D., Fruchter L., Fishel B., Holtzman M., Yaron M. Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis. Clin Rheumatol 1986, 5:527-530.
26. Taborn J., Bole G.G., Thompson G.R. Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis. Ann Intern Med 1978, 89:648-649.
27. Vereecken P., Stallenberg B., Tas S., de Dobbeleer G., Heenen M. Ulcerated dystrophic calcinosis cutis secondary to localised linear scleroderma. Int J Clin Pract 1998, 52:593-594.
28. Slimani S., Abdessemed A., Haddouche A., Ladjouze-Rezig A. Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate. Joint Bone Spine 2010, 77:70-72.
29. Ambler G.R., Chaitow J., Rogers M., McDonald D.W., Ouvrier R.A. Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy. J Rheumatol 2005, 32:1837-1839.
30. Martillotti J., Moote D., Zemel L. Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. Pediatr Radiol 2014, 44:115-118.
31. Rabens S.F., Bethune J.E. Disodium etidronate therapy for dystrophic cutaneous calcification. Arch Dermatol 1975, 111:357-361.
32. 2+ the trigger for oxygen radical production by polymorphonuclear leucocytes?. Cell Calcium 1984, 5:1-19.
33. Lian J.B., Skinner M., Glimcher M.J., Gallop P. The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification. Biochem Biophys Res Commun 1976, 73:349-355.
34. Matsuoka Y., Miyajima S., Okada N. A case of calcinosis universalis successfully treated with low-dose warfarin. J Dermatol 1998, 25:716-720.
35. Yoshida S., Torikai K. The effects of warfarin on calcinosis in a patient with systemic sclerosis. J Rheumatol 1993, 20:1233-1235.
36. Berger R.G., Featherstone G.L., Raasch R.H., McCartney W.H., Hadler N.M. Treatment of calcinosis universalis with low-dose warfarin. Am J Med 1987, 83:72-76.
37. Lassoued K., Saiag P., Anglade M.C., Roujeau J.C., Touraine R.L. Failure of warfarin in treatment of calcinosis universalis. Am J Med 1988, 84:795-796.
38. Riley P., McCann L.J., Maillard S.M., Woo P., Murray K.J., Pilkington C.A. Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatology (Oxford) 2008, 47:877-880.
39. Tosounidou S., Macdonald H., Situnayake D. Successful treatment of calcinosis with infliximab in a patient with systemic sclerosis/myositis overlap syndrome. Rheumatology (Oxford) 2014, 53:960-961.
40. Williams E.L., Gadola S., Edwards C.J. Anti-TNF-induced lupus. Rheumatology (Oxford) 2009, 48:716-720.
41. Bader-Meunier B., Decaluwe H., Barnerias C., Gherardi R., Quartier P., Faye A., et al. Safety and efficacy of rituximab in severe juvenile dermatomyositis: results from 9patients from the French Autoimmunity and Rituximab Registry. J Rheumatol 2011, 38:1436-1440.
42. Al-Mayouf S.M., Laxer R.M., Schneider R., Silverman E.D., Feldman B.M. Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. J Rheumatol 2000, 27:2498-2503.
43. Touimy M., Janani S., Rachidi W., Etaouil N., Mkinsi O. Calcinosis universalis complicating juvenile dermatomyositis: improvement after intravenous immunoglobulin therapy. Joint Bone Spine 2013, 80:108-109.
44. Reiter N., El-Shabrawi L., Leinweber B., Aberer E. Subcutaneous morphea with dystrophic calcification with response to ceftriaxone treatment. J Am Acad Dermatol 2010, 63:e53-e55.
45. Ansell B.M. Management of polymyositis and dermatomyositis. Clin Rheum Dis 1984, 10:205-213.
46. Harel L., Harel G., Korenreich L., Straussberg R., Amir J. Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications. J Rheumatol 2001, 28:1129-1132.
47. Skuterud E., Sydnes O.A., Haavik T.K. Calcinosis in dermatomyositis treated with probenecid. Scand J Rheumatol 1981, 10:92-94.
48. Eddy M.C., Leelawattana R., McAlister W.H., Whyte M.P. Calcinosis universalis complicating juvenile dermatomyositis: resolution during probenecid therapy. J Clin Endocrinol Metab 1997, 82:3536-3542.
49. Dent C.E., Stamp T.C. Treatment of calcinosis circumscripta with probenecid. BMJ 1972, 1:216-218.
50. Miyamae T., Sano F., Ozawa R., Imagawa T., Inayama Y., Yokota S. Efficacy of thalidomide in a girl with inflammatory calcinosis, a severe complication of juvenile dermatomyositis. Pediatr Rheumatol Online J 2010, 8:6.
51. Schlieper G., Brandenburg V., Ketteler M., Floege J. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol 2009, 5:539-543.
52. Wolf E.K., Smidt A.C., Laumann A.E. Topical sodium thiosulfate therapy for leg ulcers with dystrophic calcification. Arch Dermatol 2008, 144:1560-1562.
53. Ratsimbazafy V., Bahans C., Guigonis V. Dramatic diminution of a large calcification treated with topical sodium thiosulfate. Arthritis Rheum 2012, 64:3826.
54. Bair B., Fivenson D. A novel treatment for ulcerative calcinosis cutis. J Drugs Dermatol 2011, 10:1042-1044.
55. Al-Mayouf S.M., Alsonbul A., Alismail K. Localized calcinosis in juvenile dermatomyositis: successful treatment with intralesional corticosteroids injection. Int J Rheum Dis 2010, 13:e26-e28.
56. Aina R., Cardinal E., Bureau N.J., Aubin B., Brassard P. Calcific shoulder tendinitis: treatment with modified US-guided fine-needle technique. Radiology 2001, 221:455-461.
57. Touart D.M., Sau P. Cutaneous deposition diseases. Part II. J Am Acad Dermatol 1998, 39:527-544. [quiz 45-6].
58. Melone C.P., McLoughlin J.C., Beldner S. Surgical management of the hand in scleroderma. Curr Opin Rheumatol 1999, 11:514-520.
59. Merlino G., Germano S., Carlucci S. Surgical management of digital calcinosis in CREST syndrome. Aesthetic Plast Surg 2013, 37:1214-1219.
60. Sultan-Bichat N., Menard J., Perceau G., Staerman F., Bernard P., Reguiai Z. Treatment of calcinosis cutis by extracorporeal shock-wave lithotripsy. J Am Acad Dermatol 2012, 66:424-429.
61. Meissner M., Ochsendorf F., Kaufmann R. Therapy of calcinosis cutis using erbium-doped yttrium aluminum garnet laser treatment. Dermatol Surg 2010, 36:727-728.
62. Chamberlain A.J., Walker N.P. Successful palliation and significant remission of cutaneous calcinosis in CREST syndrome with carbon dioxide laser. Dermatol Surg 2003, 29:968-970.
63. Bottomley W.W., Goodfield M.J., Sheehan-Dare R.A. Digital calcification in systemic sclerosis: effective treatment with good tissue preservation using the carbon dioxide laser. Br J Dermatol 1996, 135:302-304.